# Immune Modulation by Exosomes in COVID-19

> **NCT05191381** · — · RECRUITING · sponsor: **University of Ulm** · enrollment: 40 (estimated)

## Conditions studied

- COVID-19
- Critical Illness
- Hypercytokinemia
- Lung Fibrosis

## Interventions

- **BIOLOGICAL:** Application of exosomes in a whole blood assay

## Key facts

- **NCT ID:** NCT05191381
- **Lead sponsor:** University of Ulm
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-12-22
- **Primary completion:** 2025-07-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-01-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05191381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05191381, "Immune Modulation by Exosomes in COVID-19". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05191381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*